Antipsychotic-Induced Parkinsonism: A Risk Assessment Scale and Personalised Diagnosis Algorithm
INTRODUCTION. Antipsychotic-induced parkinsonism (AIP) is an extrapyramidal adverse drug reaction (ADR) associated with antipsychotics (APs). Despite its classification as a non-serious ADR, AIP significantly decreases the quality of life in patients with schizophrenia spectrum disorders, which make...
Saved in:
Main Authors: | N. A. Shnayder (Author), E. E. Vaiman (Author), R. F. Nasyrova (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antipsychotic-Induced QT Prolongation and Torsade de Pointes in Patients with Mental Disorders: A Review
by: R. F. Nasyrova, et al.
Published: (2022) -
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
by: Marta Hernandez, et al.
Published: (2024) -
Association of a Single-Nucleotide Variant rs11100494 of the <i>NPY5R</i> Gene with Antipsychotic-Induced Metabolic Disorders
by: Vera S. Dobrodeeva, et al.
Published: (2022) -
Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
by: N. A. Shnayder, et al.
Published: (2024) -
Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid
by: N. A. Shnayder, et al.
Published: (2023)